Abstract
This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNF) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.
Original language | English |
---|---|
Pages (from-to) | 51-59 |
Number of pages | 9 |
Journal | Musculoskeletal Care |
Volume | 2 |
Issue number | 1 |
DOIs | |
Publication status | Published - Mar 2004 |
Keywords
- Podiatry
- rheumatoid arthritis
- anti-TNF therapy